Literature DB >> 6085541

Unusual molecular forms of hCG in gestational trophoblastic neoplasia.

S Amr, C Rosa, R Wehmann, S Birken, B Nisula.   

Abstract

We have observed unusual forms of human choriogonadotropin (hCG) in the urine of patients with gestational trophoblastic neoplasia. These molecules were of two types: Carboxyterminal fragments of hCG beta-subunit and desialylated forms of hCG. Substantial amounts of these materials were found in the urines of 83% and 50%, respectively, of the patients (n = 12) studied. In contrast, negligible quantities were found in the urine of 14 healthy pregnant women. Also, these unusual forms were not detectable in normal controls given an infusion of hCG. These findings indicate that these forms have clinical potential for diagnosing gestational trophoblastic neoplasia and differentiating it from normal pregnancy.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6085541

Source DB:  PubMed          Journal:  Ann Endocrinol (Paris)        ISSN: 0003-4266            Impact factor:   2.478


  4 in total

Review 1.  New discoveries on the biology and detection of human chorionic gonadotropin.

Authors:  Laurence A Cole
Journal:  Reprod Biol Endocrinol       Date:  2009-01-26       Impact factor: 5.211

2.  Carboxyterminal peptide fragments of the beta subunit are urinary products of the metabolism of desialylated human choriogonadotropin.

Authors:  S Amr; C Rosa; S Birken; R Canfield; B Nisula
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

3.  Abnormal biantennary sugar chains are expressed in human chorionic gonadotropin produced in the choriocarcinoma cell line, JEG-3.

Authors:  Shinji Takamatsu; Toshiyuki Katsumata; Noboru Inoue; Toshinori Watanabe; Yasuhisa Fujibayashi; Makoto Takeuchi
Journal:  Glycoconj J       Date:  2004       Impact factor: 2.916

4.  Combination assay of urinary beta-core fragment of human chorionic gonadotropin with serum tumor markers in gynecologic cancers.

Authors:  M Kinugasa; R Nishimura; T Koizumi; K Morisue; T Higashida; T Natazuka; T Nakagawa; T Isobe; S Baba; K Hasegawa
Journal:  Jpn J Cancer Res       Date:  1995-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.